Doust AM

No ORCID on file · 3 papers in corpus
article 2024
Clinical predictors of treatment response to gabapentin in women with unexplained chronic pelvic pain
Frontiers in pharmacology ·doi:10.3389/fphar.2024.1460206

Introduction Chronic pelvic pain affects up to 24% of women worldwide and for up to 55% of these there is no associated pathology. Despite this there are no established treatments in this cohort. This is a secondary analysis of a randomised…

other 2021
Dichloroacetate as a possible treatment for endometriosis-associated pain: a single-arm open-label exploratory clinical trial (EPiC)
Pilot and feasibility studies ·doi:10.1186/s40814-021-00797-0

BACKGROUND: Endometriosis (where endometrial-like tissue is found outside the uterus) affects ~ 176 million women worldwide and can lead to debilitating pelvic pain. There is an unmet need for new medical treatment options for endometriosis…

article 2020
Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial
Lancet (London, England) ·doi:10.1016/s0140-6736(20)31693-7

BACKGROUND: Chronic pelvic pain affects 2-24% of women worldwide and evidence for medical treatments is scarce. Gabapentin is effective in treating some chronic pain conditions. We aimed to measure the efficacy and safety of gabapentin in w…